Inhibitors of Melanogenesis: An Updated Review.

doi:10.1021/acs.jmedchem.7b00967

Paper

Inhibitors of Melanogenesis: An Updated Review.

Published May 15, 2018 · Thanigaimalai Pillaiyar, V. Namasivayam, M. Manickam

Journal of medicinal chemistry

225

Citations

5

Influential Citations

Full text

Abstract

Melanins are pigment molecules that determine the skin, eye, and hair color of the human subject to its amount, quality, and distribution. Melanocytes synthesize melanin and provide epidermal protection from various stimuli, such as harmful ultraviolet radiation, through the complex process called melanogenesis. However, serious dermatological problems occur when there is excessive production of melanin in different parts of the human body. These include freckles, melasma, senile lentigo, pigmented acne scars, and cancer. Therefore, controlling the production of melanin is an important approach for the treatment of pigmentation related disorderes. In this Perspective, we focus on the inhibitors of melanogenesis that directly/indirectly target a key enzyme tyrosinase as well as its associated signaling pathways.

Highly Cited

Study Snapshot

Inhibitors of melanogenesis, targeting tyrosinase and its signaling pathways, show promise in treating pigmentation-related disorders.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Inhibitors of Melanogenesis: An Updated Review.

References

Citations